Innovating.works Conecta tu I+D

CT-Luso: Ethics and Regulatory Capacity Building Partnership for Clinical Trials in Portuguese speaking Afric... CT-Luso intends to (1) draw an updated diagnosis and screenshot of the research ethics infrastructure in the 5 Portuguese-speaking African C...
2024-07-25 - 2027-12-31 | Financiado

STRIMHealth: Strengthening Translational Research for Improved Metabolic Health Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 Curbing obesity-related diseases is one of key priorities of the Horizon Europe 2023-2024 work programme. Although metabolic dysfunction-ass...
2024-04-04 - 2027-05-31 | Financiado

FUNAMBULIST: FUnctional Nucleic Acids as Versatile SMart BUilding BLocks in Non ConventIonal SolvenTs Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Almost half of the production costs in the rapidly growing chiral chemicals market is spent on the downstream processing costs due to challe...
2023-03-08 - 2026-04-30 | Financiado

Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology medicinal chemist... Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-INFRA-2022-TECH-01 Fragment-Screen will develop innovative instrumentation, workflows and experimental and computational methodologies for fragment-based drug...
2022-12-13 - 2026-01-31 | Financiado

More-EUROPA: More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11 While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world...
2022-11-24 - 2027-12-31 | Financiado

halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado

ISOBIOTICS: Isotopic Labeling of Biotherapeutics Faculdade de Farmcia da Universidade de Lisboa participó en un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatmen...
2022-07-14 - 2027-01-31 | Financiado

UNITE.H2020: Planning the Future of Research Innovation in the European University Alliance UNITE! Faculdade de Farmcia da Universidade de Lisboa participó en un H2020: UNITE! is one of the first 17 European University Alliances. Back in 2019, our 7 universities decided to take institutional cooperation to t...
2020-10-28 - 2023-12-31 | Financiado

Biomass4Synthons: Straightening training research and innovation capacities in the valorization of bio renewable reso... Faculdade de Farmcia da Universidade de Lisboa tramitó un H2020: H2020-WIDESPREAD-2018-2020 The overall strategic objective (Ob) of the project Biomass4Synthons, is to place the Institutions – Faculty of Pharmacy, University of Lisb...
2020-06-30 - 2024-06-30 | Financiado

LITMUS: Liver Investigation Testing Marker Utility in Steatohepatitis Faculdade de Farmcia da Universidade de Lisboa participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liv...
2017-10-09 - 2024-02-29 | Financiado

mtFOIE GRAS: mitoFOIE GRAS Non invasive Profiling of Mitochondrial Function in Non Alcoholic Fatty Liver Disease Faculdade de Farmcia da Universidade de Lisboa participó en un H2020: H2020-MSCA-RISE-2016 "Non-Alcoholic Fatty Liver Disease (NAFLD), including its more pathologic consequence, non-alcoholic steatohepatitis (NASH), is believed to...
2016-12-05 - 2022-08-31 | Financiado

Foie Gras: Bioenergetic Remodeling in the Pathophysiology and Treatment of Non Alcoholic Fatty Liver Disease Faculdade de Farmcia da Universidade de Lisboa participó en un H2020: H2020-MSCA-ITN-2016 FOIE GRAS provides innovative training for 13 early stage researchers (ESRs) to answer two critical and unanswered questions: a) Is hepatic...
2016-08-29 - 2021-06-30 | Financiado

ProteinConjugates: A training network for the chemical site selective modification of proteins Preparation of the next... Faculdade de Farmcia da Universidade de Lisboa participó en un H2020: H2020-MSCA-ITN-2015 ProteinConjugates is an inter- and multi-disciplinary network for the education of talented young scientists who will learn how to rationall...
2015-07-28 - 2019-10-31 | Financiado

FFUL